92 related articles for article (PubMed ID: 1966110)
21. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
Johnson G; Tsao PS; Mulloy D; Lefer AM
J Pharmacol Exp Ther; 1990 Jan; 252(1):35-41. PubMed ID: 2153807
[TBL] [Abstract][Full Text] [Related]
22. Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion.
Viehman GE; Ma XL; Lefer DJ; Lefer AM
Am J Physiol; 1991 Sep; 261(3 Pt 2):H874-81. PubMed ID: 1653539
[TBL] [Abstract][Full Text] [Related]
23. [Effects of insulin on cardiac function and coronary circulation in acute myocardial ischemia and reperfusion experiment with dogs].
Ma H; Huo JH; Zhang HX; Bian JF; Wang YM; Xiong LZ; Guo WY; Wang HC; Gao F
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3128-32. PubMed ID: 17313765
[TBL] [Abstract][Full Text] [Related]
24. Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion.
Ma XL; Johnson G; Lefer AM
J Am Coll Cardiol; 1992 Jan; 19(1):197-204. PubMed ID: 1729334
[TBL] [Abstract][Full Text] [Related]
25. Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablation.
Brooks DP; Contino LC; Trizna W; Edwards RM; Ohlstein EH; Solleveld HA
J Pharmacol Exp Ther; 1990 Apr; 253(1):119-23. PubMed ID: 2139468
[TBL] [Abstract][Full Text] [Related]
26. Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists.
Ge ZD; Auchampach JA; Piper GM; Gross GJ
J Cardiovasc Pharmacol; 2003 Mar; 41(3):481-8. PubMed ID: 12605028
[TBL] [Abstract][Full Text] [Related]
27. S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium.
Delyani JA; Nossuli TO; Scalia R; Thomas G; Garvey DS; Lefer AM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1174-80. PubMed ID: 8968338
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia-reperfusion in vivo.
Gourine AV; Bulhak AA; Gonon AT; Pernow J; Sjöquist PO
Nitric Oxide; 2002 Nov; 7(3):210-6. PubMed ID: 12381417
[TBL] [Abstract][Full Text] [Related]
29. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
[TBL] [Abstract][Full Text] [Related]
30. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation.
Sato H; Jordan JE; Zhao ZQ; Sarvotham SS; Vinten-Johansen J
Ann Thorac Surg; 1997 Oct; 64(4):1099-107. PubMed ID: 9354535
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of limb and myocardial ischemia postconditioning with acute myocardial reperfusion injury].
Zhang XH; Li CM; Ma XJ; Luo M
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):841-5. PubMed ID: 16681977
[TBL] [Abstract][Full Text] [Related]
32. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.
Jordan JE; Zhao ZQ; Sato H; Taft S; Vinten-Johansen J
J Pharmacol Exp Ther; 1997 Jan; 280(1):301-9. PubMed ID: 8996210
[TBL] [Abstract][Full Text] [Related]
33. Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Faggiotto A; Caputi AP
Agents Actions; 1993 Jul; 39(3-4):143-9. PubMed ID: 8304242
[TBL] [Abstract][Full Text] [Related]
34. Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion.
Lefer AM; Johnson G; Ma XL; Tsao PS; Thomas GR
Br J Pharmacol; 1991 May; 103(1):1153-9. PubMed ID: 1652342
[TBL] [Abstract][Full Text] [Related]
35. Coronary vascular injury due to ischemia-reperfusion is reduced by pentoxifylline.
Dauber IM; Lesnefsky EJ; Ashmore RC; Martel DM; Sheridan FM; Weil JV; Horwitz LD
J Pharmacol Exp Ther; 1992 Mar; 260(3):1250-6. PubMed ID: 1312165
[TBL] [Abstract][Full Text] [Related]
36. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.
Tsao PS; Aoki N; Lefer DJ; Johnson G; Lefer AM
Circulation; 1990 Oct; 82(4):1402-12. PubMed ID: 2401073
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.
Lefer AM; Ma XL; Weyrich AS; Scalia R
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1018-22. PubMed ID: 8381531
[TBL] [Abstract][Full Text] [Related]
38. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
Schrör K; Thiemermann C; Ney P
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
[TBL] [Abstract][Full Text] [Related]
39. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats.
Hayward R; Campbell B; Shin YK; Scalia R; Lefer AM
Cardiovasc Res; 1999 Jan; 41(1):65-76. PubMed ID: 10325954
[TBL] [Abstract][Full Text] [Related]
40. Prevention of coronary vascular abnormalities early in reperfusion with TGF-beta may not prevent late coronary vascular injury.
Keller M; Kong Y; Robertson AD; Horwitz L
J Cardiovasc Pharmacol; 1997 Aug; 30(2):197-204. PubMed ID: 9269947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
